WormMine: RNAi WBRNAi00071235

• WormBase ID: WBRNAi00071235
• Genotype: bIs1(vit-2::GFP); rrf-3(pk1426)
• Phenotype Remark: RNAi treatment resulted in an abnormal accumulation of YP170-GFP in the body cavity.
• Remark: Primary screen. L1 larval stage was applied to induced RNAi cultures.

1 Organism

• Name: Caenorhabditis elegans
• Taxon Id: 6239

1 Data Sets

• WormBaseAcedbConverter

2 Inhibits Gene

WormBase Gene ID	Gene Name	Sequence Name	Organism
WBGene00002996	lin-7	Y54G11A.10	Caenorhabditis elegans
WBGene00185067	Y54G11A.17	Y54G11A.17	Caenorhabditis elegans

3 Inhibits Predicted Gene

WormMine ID	Sequence Name	Length (nt)	Chromosome Location
CDS:Y54G11A.10a	Y54G11A.10a	630	II: 14347162-14347356
CDS:Y54G11A.10b	Y54G11A.10b	627	II: 14347162-14347356
CDS:Y54G11A.17	Y54G11A.17	375	II: 14348986-14349195

1 Laboratories

Primary Identifier
RT

2 Phenotype

Identifier	Name	Description
WBPhenotype:0000961	pattern of transgene expression variant	Any variation in the cellular or subcellular pattern of expression of a gene product produced by exogenous DNA that has been introduced into the organism compared to its expression in control animals.
WBPhenotype:0001425	receptor mediated endocytosis defective	Animals exhibit defects in the cell-mediated uptake of external materials via receptor activity. Receptor-mediated endocytosis ensures specificity of transport and generally occurs via clathrin-coated pits and vesicles. In C. elegans, this is often judged by the lack of yolk uptake in oocytes.

0 Phenotype _ Not _ Observed

1 Reference

First Author	Title	Year	Journal	Volume	Pages	PubMed ID
						WBPaper00030951

0 Strain